TDOC
Get informed when a big investor buys or sells
+ FollowUndervalued by 204.1% based on the discounted cash flow analysis.
| Market cap | $1.12 Billion |
|---|---|
| Enterprise Value | $1.43 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1.14 |
| Beta | 2.13 |
| Outstanding Shares | 180,079,395 |
| P/E Ratio | -6.22 |
|---|---|
| PEG | -32.53 |
| Price to Sales | 0.5 |
| Price to Book Ratio | 0.93 |
| Enterprise Value to Revenue | 0.58 |
| Enterprise Value to EBIT | -8.41 |
| Enterprise Value to Net Income | -9 |
| Total Debt to Enterprise | 0.76 |
| Debt to Equity | 0.83 |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.7333▲ 0.07% |
|---|---|
| Total Calls | 5,911,110▲ 4.00% |
| Total Puts | 4,334,356▲ 4.10% |
Holdings and activity of institutional investors.
| Ownership % | 86.30%▲ 6.21% |
|---|---|
| Total Invested | $1.32B▲ 68.09% |
| Investors Holding | 377▲ 25.00% |
No data
Teladoc Health empowers all people everywhere to live their healthiest lives by transforming the healthcare experience. As the world leader in whole-person virtual care, Teladoc Health uses proprietary health signals and personalized int...